Blood level monitoring could speed sepsis recovery
NCT ID NCT07270523
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether adjusting beta-lactam antibiotics based on blood levels helps critically ill sepsis patients recover faster. 198 adults in the ICU will be randomly assigned to either standard dosing or dosing guided by regular blood tests. The goal is to see if personalized dosing reduces time to full clinical recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
beta-lactam antibiotics
What this could lead to
If successful, this could show that personalized antibiotic dosing helps sepsis patients recover faster and reduces hospital stays.
What could go wrong
This is a single-center trial with 198 patients, so results may not apply broadly. The intervention is monitoring, not a new drug, so the impact may be modest.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
Clinical Hospital of Santiago de Compostela
Santiago de Compostela, A Coruña, 15705, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••